FDA Investigator Tina S Roecklein

Tina S Roecklein has conducted inspections on 17 sites in 6 countries as of 21 Jan 2016. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
17
Last Inspection Date:
21 Jan 2016
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
Canada, Italy, United States of America, Belgium, France, Ireland
FDA Investigators that have inspected at least one site in common with Tina S Roecklein:
Alanna L Mussawwir Bias, Alexander M Kay, Alicia M Mozzachio, Alla Kachko, PhD, Amber D Brodas, Amy S Graf, Anastasia I Offordile, Anissa M Cheung, Anita Narula, PhD, Anita R Michael, Anita Verma, Ann L Demarco, Ann Marie Montemurro, Ann Marie Schofield, Anthony F Lorenzo, Antonina Aydanian, Art O Czabaniuk, Ashar P Parikh, Astrida B Mattson, Audrey Thereset Uy, Azza Talaat, Barbara Janine Breithaupt, Bei Y He, Bijoy Panicker, Bradley Dworak, PhD, Brentley S Collins, Brian S Keefer, Burnell M Henry, Caryn M Mcnab, CDR Donald Ertel, CDR Jeremy L Wally, PhD, Chao Ming Tsai, Charles Jewell, Christian D Lynch (CDL), Christina J Sauder, PhD, Christine A Harman, PhD, Christopher J Adams, Connie P Rezendes, Craig D Zagata, Cynthia J Lee, MS, Cynthia Jim, CSO, Daniel J Brown, Darla J Christopher, Dave Hafner, David J Hafner, Dawn E Barkans, Deborah M Trout, Debra J Bennett, Debra L Pagano, Demitria J Argiropoulos, Demitria J Xiradakis, Dennis E Guilfoyle, PhD, Destry M Sillivan, Diana Kouiavskaia, Diane L Raccasi, Dino A Fiegelstock, Dmitriy V Volokhov, PhD, Dolores E Price, Don H Bark, PhD, Donald L Lech, Dr. Gang Wang, PhD, Dr. Willie F Vann, PhD, Dr. Zhihao Qiu (Peter), PhD, Edmund F Mrak, Jr, Edwin Melendez, Eileen A Liu, Eliezar Ramos, Ellen Huang, Emilie E Kahn, Emily J Orban, Eric Peng, Freyja V Lynn, Gene D Arcy, Gerard Pde Leon, Gloria J Baca, MS, Hailin Wang (Sheena), PhD, Hala L Selby, Haruhiko Murata, Heika R Bounds, Heika R Tait, Helen B Ricalde, J David Doleski, Jacob G Lutz, Jacqueline Mdiaz Albertini, Jacqueline S Warner, James C Maclaughlin, James E Keller, PhD, James M Mason, James R Evans, Jeffrey D Meng, Jennifer L Bridgewater, Jennifer L Schmidt, Joan A Loreng, Joan Adamo, Joan Johnson, Joanne M Hajoway, Joey V Quitania, John F Cipollo, John M Mcinnis, Jonathan Mclnnis, Joohi Castelvetere, Joseph A Piechocki, Joseph George, Joseph T Madak, Julianne C Mccullough, Julie D Bringger, Junho Pak, Justin A Boyd, Karen L Kosar, Kari M Johansen, Karyn M Campbell, Kathleen B Mihalik, Kathryn A Krentz, Kathryn Carbone, MD, Kelly N Kerr, Kelly R Lewis, Kenneth M Gordon, Kenneth O Gee, PhD, Kevin A Gonzalez, Kevin P Foley, Kirsten L Vadheim, PhD, Kristen D Evans, Kristin M Abaonza, Kristina L Conroy, Larry K Austin, Lata C Mathew, PhD, Laureen F Kononen, Laurel A Beer, Lauren M Lilly, PhD, Laurie P Norwood, LCDR Debra Emerson, LCDR Margaret Edi Gennaro, Leslie D Wagner, Linda Thai, Lindsey Brown, PhD, Lisa K Capron, Lisa M Bellows, Lisa M Feola, Lori Peters, LT John M Mastalski, Lynda L Perry, PhD, Madushini Dharmasena, PhD, Maria Joselopez Barragan, PhD, Maria Pkelly Doggett, MBA, Marian E Major, PhD, Marian Majors, PhD, Marijo B Kambere, PhD, Marion Michaelis, Mariza M Jafary, Marjorie A Shapiro, PhD, Mark W Babbitt, Marsha W Major, Martha T Olone, Mary Davis Lopez, Mate Tolnay, Matthew A Spataro, Maxine H Wong, Miah I Schneider, Michael Curbarg, Michael Gurbarg, Michael Shanks, MS, Michele L Forster, PhD, Michele L Obert, Mihaly S Ligmond, Mikel T Wright, Milan S Blake, Nancy T Waites, Nawab A Siddiqui, Nicole K Trudel, Nikisha M Bolden, Omotunde O Osunsanmi, Pankaj H Amin, Patrick C Klotzbuecher, Patsy J Domingo, Paul Mouris, Paul W Keller, Paula A Trost, Perry T Nichols, Pote Amin, Prabhu P Raju, Ramon E Martinez, Randy L Self, Rebecca E Dombrowski, Rebecca K Olin, Rebecca Rodriguez, Richard W Thornton, Robert B Shibuya, MD, Robert D Tollefsen, Robert Jennings, Robert Sausville, Robin Levis, PhD, Roger F Zabinski, Ronald E Lundquist, Rose Ashley, S Lori Brown, PhD MPH, Salwa K Poole, Sangeeta M Khurana, PhD, Sangeeta M Rataul, Sanket N Patel, Sarah B Tanksley, Sarah E Rhoades, Sarah M Meng, Sarah M Napier, Scott E Norris, Sheila Dreher Lesnick, Shirshendu K Deb, PhD, Shuang Tang, Sidney B Priesmeyer, Simone E Pitts, Solomon Yimam (SY), Stephanie Mangigian, MS/OSH, RN, Stephen D Brown, Steven A Rubin, Steven C Derrick, Susan F Laska, MS, Susan M Jackson, Tammy L Chavis, Terri L Dodds, Thomas J Arista, Tina Buecklein, Tina M Pawlowski, Tracy K Li, Travis S Bradley, Uttaniti Limchumroon (Tom), Vlada Matusovsky, Wayne E Seifert, Wei Wang, PhD, Xiao Wang, Xiomara Copeland, Xu Michael Di, PhD, Yvins Dezan

Tina S Roecklein's Documents

Publish Date Document Type Title
April, 2006 FDA 483 Sanofi Pasteur Inc. - Form 483, 2006-04-28
June, 2008 FDA 483 Response GlaxoSmithKline Biologicals SA - Form 483R, 2008-06-25
September, 2013 FDA 483 Sanofi Pasteur Limited - Form 483, 2013-09-20
June, 2012 FDA 483 Pfizer Ireland Pharmaceuticals - Form 483, 2012-06-28
July, 2008 FDA 483 Sanofi Pasteur Limited - Form 483, 2008-07-24
July, 2008 EIR Sanofi Pasteur Limited - EIR, 2008-07-24
June, 2008 FDA 483 GlaxoSmithKline Biologicals SA - Form 483, 2008-06-25
September, 2013 FDA 483 Response Sanofi Pasteur Limited - Form 483R, 2013-10-11
June, 2011 FDA 483 GlaxoSmithKline Vaccines Srl - Form 483, 2011-06-24
April, 2012 FDA 483 Sanofi Pasteur Limited - Form 483, 2012-04-25
June, 2014 FDA 483 Pfizer Ireland Pharmaceuticals - Form 483, 2014-06-17
June, 2014 EIR Pfizer Ireland Pharmaceuticals - EIR, 2014-06-17
October, 2012 FDA 483 GlaxoSmithKline Biologicals SA - Form 483, 2012-10-05
January, 2008 FDA 483 Merck Sharp & Dohme LLC - Form 483, 2008-01-17
October, 2010 FDA 483 Wyeth Pharmaceutical Division of Wyeth Holdings LLC - Form 483, 2010-10-01
December, 2010 FDA 483 Jubilant HollisterStier LLC - Form 483, 2010-12-15
June, 2008 EIR GlaxoSmithKline Biologicals SA - EIR, 2008-06-25
April, 2012 EIR Sanofi Pasteur Limited - EIR, 2012-04-25
May, 2014 FDA 483 Sanofi Pasteur Inc. - Form 483, 2014-05-09
January, 2016 FDA 483 Sanofi Pasteur - Form 483, 2016-01-28
June, 2015 FDA 483 GlaxoSmithKline Vaccines Srl - Form 483, 2015-06-26
June, 2011 EIR GlaxoSmithKline Vaccines Srl - EIR, 2011-06-24
February, 2013 FDA 483 Merck Sharp & Dohme LLC - Form 483, 2013-02-06
May, 2014 EIR Sanofi Pasteur Inc. - EIR, 2014-05-09
November, 2014 EIR ENDO USA, Inc. - EIR, 2014-11-22

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more